WordNet
- meet at breast level; "The runner breasted the tape"
- the part of an animals body that corresponds to a persons chest
- either of two soft fleshy milk-secreting glandular organs on the chest of a woman (同)bosom, knocker, boob, tit, titty
- the front of the trunk from the neck to the abdomen; "he beat his breast in anger" (同)chest
- meat carved from the breast of a fowl (同)white_meat
- having a breast or breasts; or breasts as specified; used chiefly in compounds; "small-breasted"; "red-breasted sandpiper"
- examination of tissues or liquids from the living body to determine the existence or cause of a disease
PrepTutorEJDIC
- 『胸』,『胸部』;(服の)胸部 / 『乳房』,乳 / 《文》胸中,心紳 / …'を'胸に受ける,胸に受けて進む / …‘に'雄々しく立ち向かう
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/09/15 08:39:42」(JST)
[Wiki en表示]
Breast biopsy |
Intervention |
Surgeon doing a surgical breast biopsy
|
ICD-9-CM |
85.11-85.12 |
[edit on Wikidata]
|
Several methods for a breast biopsy now exist. The most appropriate method of biopsy for a patient depends upon a variety of factors, including the size, location, appearance and characteristics of the abnormality.
Contents
- 1 Fine needle aspiration
- 2 Vacuum assisted biopsy
- 3 Direct and frontal biopsy
- 4 References
Fine needle aspiration
Main article: Fine-needle aspiration
Fine needle aspiration (FNA) is a percutaneous ("through the skin") procedure that uses a fine needle and a syringe to sample fluid from a breast cyst or remove clusters of cells from a solid mass.
Vacuum assisted biopsy
Vacuum assisted biopsy is a version of core needle biopsy using a vacuum technique to assist the collection of the tissue sample. The needle normally has a lateral ("from the side") opening and can be rotated allowing multiple samples to be collected through a single skin incision. The Vacuum assisted biopsy procedure is similar to normal core needle biopsy. The vacuum assisted biopsy category also includes automated rotational core devices.[1]
Direct and frontal biopsy
Recent innovations in tissue acquisition for the human breast have led to the development of unique direct frontal systems. Efficacy is considered optimal if the diagnosis by transcutaneous biopsy is identical to the surgical specimen in case of malignancy or in line with clinical follow-up when benign.[citation needed]
The direct and frontal biopsy systems can even be considered relatively painless. The quality of the sample is sufficient for research on molecular biology.[2][3][4]
References
- ^ "ADVANCE for Health Information Professionals - Editorial". advanceweb.com.
- ^ Cornelis A, Verjans M, Van den Bosch T, Wouters K, Van Robaeys J, Janssens JP (August 2009). "Efficacy and safety of direct and frontal macrobiopsies in breast cancer". Eur. J. Cancer Prev. 18 (4): 280–4. doi:10.1097/CEJ.0b013e328329d885. PMID 19352188.
- ^ High-Precision Direct and Frontal Breast Biopsy to Assure Adequate Surgical Margin Interpretation; Jaak Janssens, MD, PhD; Ruediger Schulz-Wendtland, MD, PhD; Luc Rotenberg, MD; John-Paul Bogers, MD, PhD
- ^ Goss, Paul E.; Ingle, James N.; Alés-Martínez, José E.; Cheung, Angela M.; Chlebowski, Rowan T.; Wactawski-Wende, Jean; McTiernan, Anne; Robbins, John; Johnson, Karen C.; Martin, Lisa W.; Winquist, Eric; Sarto, Gloria E.; Garber, Judy E.; Fabian, Carol J.; Pujol, Pascal; Maunsell, Elizabeth; Farmer, Patricia; Gelmon, Karen A.; Tu, Dongsheng; Richardson, Harriet (23 June 2011). "Exemestane for Breast-Cancer Prevention in Postmenopausal Women (Breast enlargement with surgery))". New England Journal of Medicine. 364 (25): 2381–2391. doi:10.1056/NEJMoa1103507.
Operations/surgeries and other procedures of the breast (ICD-9-CM V3 85, ICD-10-PCS 0H)
|
|
Breast surgery |
- Breast-conserving surgery
- Mastectomy
- Mammoplasty
- Breast implant
- Breast reduction plasty
- Mastopexy
- Breast reconstruction
- Interventions on the Lactiferous ducts
- Ductal lavage
- Ductoscopy
- Microdochectomy
- Central duct excision
|
|
Breast imaging |
- Mammography
- Positron emission mammography
- Tomosynthesis
- Xeromammography
- Galactography
- Breast MRI
- Breast ultrasound
- Automated whole-breast ultrasound
- Scintimammography
- Tactile imaging
|
|
Other |
- Breast cancer screening
- Breast self-examination
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Accurate characterization of benign and cancerous breast tissues: Aspecific patient studies using piezoresistive microcantilevers.
- Pandya HJ1, Roy R2, Chen W3, Chekmareva MA4, Foran DJ3, Desai JP2.
- Biosensors & bioelectronics.Biosens Bioelectron.2015 Jan 15;63:414-24. doi: 10.1016/j.bios.2014.08.002. Epub 2014 Aug 7.
- Breast cancer is the largest detected cancer amongst women in the US. In this work, our team reports on the development of piezoresistive microcantilevers (PMCs) to investigate their potential use in the accurate detection and characterization of benign and diseased breast tissues by performing inde
- PMID 25128621
- Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer.
- Kast K1, Schmutzler RK, Rhiem K, Kiechle M, Fischer C, Niederacher D, Arnold N, Grimm T, Speiser D, Schlegelberger B, Varga D, Horvath J, Beer M, Briest S, Meindl A, Engel C.
- International journal of cancer. Journal international du cancer.Int J Cancer.2014 Nov 15;135(10):2352-61. doi: 10.1002/ijc.28875. Epub 2014 Apr 25.
- The Manchester scoring system (MSS) allows the calculation of the probability for the presence of mutations in BRCA1 or BRCA2 genes in families suspected of having hereditary breast and ovarian cancer. In 9,390 families, we determined the predictive performance of the MSS without (MSS-2004) and with
- PMID 24700448
- Interference-Free HER2 ECD as a Serum Biomarker in Breast Cancer.
- Lam L1, Czerniecki BJ2, Fitzpatrick E2, Xu S2, Schuchter L3, Xu X1, Zhang H1.
- Journal of molecular biomarkers & diagnosis.J Mol Biomark Diagn.2014 Nov 14;4(3):151.
- Over-expression of the HER2/neu receptor occurs in 20 to 30 percent of breast tumors and is linked to poorer prognosis. The HER2/neu expression status determines whether or not patient will receive trastuzumab-based treatment. In clinical practice, over-expression of HER2/neu is routinely identified
- PMID 25089226
Japanese Journal
- A novel diagnostic method targeting genomic instability in intracystic tumors of the breast
- 経過観察中に縮小した乳癌の1例 (JABTS 33/パネルディスカッション 経過観察中に縮小した乳癌,その原因は? 組織型は?)
Related Links
- Learn about the different types of breast biopsy procedures, which are used to remove suspicious breast growth and examined for the presence of cancer. ... Breast biopsy facts A breast biopsy procedure is usually done to determine ...
- Breast Biopsy Definition A breast biopsy is removal of breast tissue for examination by a pathologist. This can be accomplished surgically, or by withdrawing tissue through a needle. Purpose A biopsy is recommended when a ...
Related Pictures
★リンクテーブル★
[★]